Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here

Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News

Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Conditions:   Cystic Fibrosis;   Contraception
Sponsor:   University of Washington
Not yet recruiting

Tue, 29 Sep 2020 12:00:00 EDT

Bariatric Surgery and Fatty Liver Disease
Conditions:   Morbid Obesity;   Diabetes;   Hypertension
Interventions:   Diagnostic Test: Biochemistry analysis;   Diagnostic Test: NAFLD fibrosis score;   Other: BMI measurement;   Diagnostic Test: Fibrosis 4 Index;   Diagnostic Test: Fatty Liver Index
Sponsors:   University Hospital Ostrava;   University of Ostrava

Tue, 29 Sep 2020 12:00:00 EDT

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle Sheet
Sponsor:   Anterogen Co., Ltd.

Tue, 29 Sep 2020 12:00:00 EDT

Diabetes Communication and Treatment Burden
Conditions:   Diabetes Mellitus, Type 2;   Multiple Chronic Conditions
Interventions:   Other: CI-PVP (context-informed pre-visit planning);   Other: Standard PVP (pre-visit planning)
Sponsor:   University of California, Davis
Enrolling by invitation

Tue, 29 Sep 2020 12:00:00 EDT

Rural Dwelling Older Adults With T2DM (Study 2)
Condition:   Type 2 Diabetes
Intervention:   Other: Diabetes Empowerment Education Program
Sponsor:   Brittany L Smalls
Not yet recruiting

Tue, 29 Sep 2020 12:00:00 EDT

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients
Condition:   Type II Diabetes
Interventions:   Drug: PAZ320;   Other: Placebo
Sponsor:   Boston Therapeutics

Tue, 29 Sep 2020 12:00:00 EDT

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management
Conditions:   Diabetic Ketoacidosis;   Type 1 Diabetes;   Type 2 Diabetes
Interventions:   Drug: Glargine;   Other: IV insulin infusion;   Other: IV fluid and electrolytes replacement
Sponsor:   The Cleveland Clinic
Not yet recruiting

Mon, 28 Sep 2020 12:00:00 EDT

Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water
Condition:   Body Weight
Interventions:   Behavioral: Maintain SSBs (Control);   Behavioral: Substitute Aspartame ASBs;   Behavioral: Substitute Sucralose ASBs;   Behavioral: Substitute Water
Sponsors:   Brigham and Women's Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting

Mon, 28 Sep 2020 12:00:00 EDT

Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases(NCD)
Conditions:   Lifestyle Intervention;   Non Communicable Diseases
Interventions:   Behavioral: Intensive intervention group;   Behavioral: standard intervention group
Sponsor:   Beijing Tsinghua Chang Gung Hospital

Mon, 28 Sep 2020 12:00:00 EDT

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
Condition:   Diabetic Retinopathy (DR)
Interventions:   Biological: RGX-314 Dose 1;   Biological: RGX-314 Dose 2
Sponsor:   Regenxbio Inc.
Not yet recruiting

Mon, 28 Sep 2020 12:00:00 EDT

Remote Ischemic Conditioning and Diabetic Foot Ulcers
Conditions:   Diabetic Foot Ulcer;   Diabetic Angiopathies
Intervention:   Device: Remote Ischemic conditioning (RIC)
Sponsors:   Des Moines University;   Iowa State University
Not yet recruiting

Mon, 28 Sep 2020 12:00:00 EDT

Self-Management Interventions Using Mobile Health for the Multimorbid
Condition:   Multiple Chronic Conditions
Interventions:   Behavioral: mHealth intervention;   Behavioral: mHealth Plus
Sponsors:   University of Nebraska;   Greater Plains Collaborative Clinical Data Research Network

Mon, 28 Sep 2020 12:00:00 EDT

A Phase 2b Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes Mellitus
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: ORMD-0801;   Other: Placebo
Sponsor:   Oramed, Ltd.
Not yet recruiting

Fri, 25 Sep 2020 12:00:00 EDT

A Study to Evaluate the Safety and Tolerability of EXN407
Condition:   Diabetic Macular Edema
Intervention:   Drug: EXN407
Sponsors:   Exonate Limited;   Novotech (Australia) Pty Limited
Not yet recruiting

Fri, 25 Sep 2020 12:00:00 EDT

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot
Conditions:   Diabetic Foot Ulcer;   Diabetic Foot
Interventions:   Other: Medaxis Debritom+;   Other: Sharp Surgical Debridement;   Other: Additional Outer Dressing Application;   Other: Offloading;   Other: Fibracol Wound Dressing
Sponsors:   Professional Education and Research Institute;   Medaxis AG

Fri, 25 Sep 2020 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News

FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants
FDA issued guidance for certain labeling recommendations for breast implants as part of the agency’s effort to improve the information available to patients and health care professionals about the risks of breast implants.

Mon, 28 Sep 2020 18:16:32 EDT

FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years
Today FDA approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood related cause of the disease.

Fri, 25 Sep 2020 16:00:40 EDT

Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020
FDA issues an updated summary of the agency’s COVID-19 response efforts.

Fri, 25 Sep 2020 15:53:15 EDT

FDA Takes Actions to Help Lower U.S. Prescription Drug Prices
Today, HHS and FDA took actions to help provide safe, effective, and more affordable drugs to American patients by completing the rulemaking to allow states to import certain prescription drugs from Canada.

Thu, 24 Sep 2020 17:51:43 EDT

Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020
Coronavirus (COVID-19) Update: Daily Roundup

Thu, 24 Sep 2020 16:52:57 EDT

FDA Issues Recommendations for Certain High-Risk Groups Regarding Mercury-Containing Dental Amalgam
FDA issues updated recommendations on dental amalgam and potential risks to certain high-risk individuals that may be associated with mercury-containing fillings used to restore the missing structure and surfaces of a decayed tooth.

Thu, 24 Sep 2020 13:33:33 EDT

Coronavirus (COVID-19) Update: FDA Authorizes First Point-of-Care Antibody Test for COVID-19
Today, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19.

Wed, 23 Sep 2020 20:40:52 EDT

Coronavirus (COVID-19) Update: Daily Roundup September 23, 2020
Coronavirus (COVID-19) Update: Daily Roundup

Wed, 23 Sep 2020 18:16:40 EDT

FDA Requiring Labeling Changes for Benzodiazepines
FDA issues a Drug Safety Communication announcing a class-wide labeling change for benzodiazepines to include the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions to help improve their safe use.

Wed, 23 Sep 2020 14:52:11 EDT

FDA Achieves Key Milestone, Finalizes Framework That Will Resume Shellfish Trade with Europe for the First Time in 10 Years
FDA finalized a molluscan shellfish equivalence determination for two European Union (EU) Member States, Spain and the Netherlands

Wed, 23 Sep 2020 12:10:36 EDT
Diabetes news from the American Diabetes Association

Latest Top (5) News